Pre-Open Stock Movers 01/06: (TATT) (CHNG) (SCYX) Higher; (TMDI) (GBX) (NEO) Lower (more...)

January 6, 2021 9:27 AM EST

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Today's Pre-Open Stock Movers:

TAT Technologies Ltd. (NASDAQ: TATT) 49.6% HIGHER; announced today that its fully owned subsidiary, TAT Piedmont Aviation, and Honeywell International, had entered into a 10-year agreement for an exclusive worldwide Auxiliary Power Unit (APU) rental services for OEM authorized GTCP331-500 engine. This engine is installed in all Boeing 777 aircraft around the world. Under this contract TAT-Piedmont will offer rental services to airlines who are operating Boeing's 777 aircraft and will serve on behalf of Honeywell for any rental of Honeywell GTCP331-500 APUs to all of Honeywell's customers on an exclusive basis.

Change Healthcare (NASDAQ: CHNG) 32.8% HIGHER; Optum, a diversified health services company and part of UnitedHealth Group (NYSE: UNH), and Change Healthcare (NASDAQ: CHNG), a health care technology leader, have agreed to combine. Change Healthcare will join with OptumInsight to provide software and data analytics, technology-enabled services and research, advisory and revenue cycle management offerings to help make health care work better for everyone.

Titan Medical Inc. (Nasdaq: TMDI) 13.8% LOWER; entered into an agreement with Bloom Burton Securities Inc. (the Underwriter) pursuant to which the Underwriter has agreed to purchase, on a bought deal basis, 6,451,613 units of the Company (the Units) at a price of US$1.55 per Unit (the Offering Price) for aggregate gross proceeds of US$10,000,000 (the Offering).

SCYNEXIS (NASDAQ: SCYX) 6.9% HIGHER; Cantor Fitzgerald initiates coverage with an Overweight rating and a price target of $30.00.

Cal-Maine Foods (NASDAQ: CALM) 6% HIGHER; reported Q2 EPS of $0.25, $0.33 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $347.3 million versus the consensus estimate of $333.5 million.

Greenbrier Cos. (NYSE: GBX) 5.8% LOWER; reported Q1 EPS of ($0.30), $0.23 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $402.99 million versus the consensus estimate of $481.03 million.

NeoGenomics, Inc. (NASDAQ: NEO) 5% LOWER; commenced proposed underwritten public offerings of approximately $200,000,000 of newly issued shares of common stock and $250,000,000 aggregate principal amount of convertible senior notes due 2028.

Neoleukin Therapeutics (NASDAQ: NLTX) 4.2% HIGHER; Stifel initiates coverage with a Buy rating and a price target of $18.00.

Ardelyx, Inc (NASDAQ: ARDX) 3.2% HIGHER; Cantor Fitzgerald initiates coverage with an Overweight rating and a price target of $14.00.

Myovant Sciences Ltd. (NYSE: MYOV) 3.2% LOWER; Goldman Sachs downgraded from Buy to Neutral with a price target of $30.00.

DXC Technology (NYSE: DXC) 3% LOWER; BofA Securities downgraded from Buy to Underperform with a price target of $24.00.

China Mobile Limited (NYSE: CHL) 3% LOWER; NYSE Weighs Reverting to Original Plan to Delist China Shares - Bloomberg

China Unicom (Hong Kong) Limited (NYSE: CHU) 2.5% LOWER; NYSE Weighs Reverting to Original Plan to Delist China Shares - Bloomberg

Alibaba (NYSE: BABA) 2% LOWER; Trump signs order banning transactions with eight Chinese apps including Alipay

Tesla, Inc. (NASDAQ: TSLA) 1.9% HIGHER; Morgan Stanley raises price target to 'Street High' $810.

China Telecom Corporation Limited (NYSE: CHA) 1.6% LOWER; NYSE Weighs Reverting to Original Plan to Delist China Shares - Bloomberg



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

Stifel, Cantor Fitzgerald, Goldman Sachs, Morgan Stanley, Tesla, Pre-Open Losers, Pre-Open Winners, Pre Market Movers